The first purpose of this study is to determine if dopamine synthesis capacity is
significantly lower in treatment non-responders from illness onset relative to treatment
responders. And the second purpose of this study is to determine the potential of [18
fluorine(F)]-DOPA to be used to predict treatment response to antipsychotic treatment in
first episode psychosis.